ArticleAmerican journal of obstetrics and gynecology2024

The end is where we start from: withdrawal of 17-alpha hydroxyprogesterone caproate to prevent recurrent preterm birth.

David B Nelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.